Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

The Novartis Speakers Bureau

Last week, Novartis agreed to pay a $185 million criminal fine for off-label marketing of the epilepsy drug Trileptal, and $237.5 million to resolve civil allegations over kickbacks paid to doctors to prescribe Trileptal and five other drugs.… Continue Reading

Someone Tell The Lawyers

The International Bar Association (IBA) said about half the world’s lawyers haven’t heard of the FCPA. Seventy percent are unaware of the U.K. Bribery Act, and four in ten don’t know about the OECD and U.N.… Continue Reading

Enforcement Report For Q3 ’10

After the busiest first quarter on record for FCPA enforcement, things were quiet from April to June. But during the quarter just ended, there was plenty of action. It included the sputtering end to James Giffen’s high-profile prosecution, the Greens’ ultra-light jail term, a settlement by Snamprogetti that ranked fourth on our all-time top ten list, and ABB’s deal this week that will land seventh.… Continue Reading